SPR741 acetate ynyboquinone [O-]P(O)(=O)OP([O-])(=O)OC[C@H]1O[C@H]([C@H](O)[C@@H]1O)N1C=CC(=O)NC1=O

[O-]P(O)(=O)OP([O-])(=O)OC[C@H]1O[C@H]([C@H](O)[C@@H]1O)N1C=CC(=O)NC1=O

15]dioxa[4

Pomalidomide4PEG5-acid

Interaction of canertinib with OATP1B3 may alter its hepatic disposition and can lead to transporter mediated drug-drug interactions

A direct interaction of clozapine with the GABAB receptor has also been shown

SPR741 acetate ynyboquinone [O-]P(O)(=O)OP([O-])(=O)OC[C@H]1O[C@H]([C@H](O)[C@@H]1O)N1C=CC(=O)NC1=OSPR741 acetate (NAB741 acetate) is a cationic peptide derived from polymyxin B and is a potentiator molecule. SPR741 acetate increases the permeability of the outer membrane of Gram negative bacteria and is used to treat severe Gram negative bacteria infections. SPR741 acetate inhibits multidrug resistant Gram negative bacteria. The spectrum of activity of the antibiotic can be widened when used in combination with SPR741 acetate. Product information